Novel Aza-resveratrol analogs: synthesis, characterization and anticancer activity against breast cancer cell lines

Novel Aza-resveratrol analogs were synthesized, structurally characterized and evaluated for cytotoxic activity against MDA-MB-231 and T47D breast Cancer cell lines, which exhibited superior inhibitory activity than parent resveratrol compound. The binding mechanism of these compounds with estrogen receptor-α was rationalized by molecular docking studies which indicated additional hydrogen binding interactions and tight binding in the protein cavity. Induction of Beclin-1 protein expression in breast Cancer cell lines after treatment with newly synthesized resveratrol analogs indicated inhibition of growth of these cell lines through Autophagy. The study highlighted the advantage of introducing the imino-linkage in resveratrol motif in enhancing the Anticancer potential of resveratrol suggesting that these analogs can serve as better therapeutic agents against breast Cancer and can provide starting point for building more potent analogs in future.